Eledon Pharmaceuticals (Eldn) Appoints Eliezer Katz As Chief Medical Officer
10/23/23, 11:13 AM
Location
irvineIndustry
biotechnology
Position
chief medical officer
Eledon Pharmaceuticals, Inc. today announced the appointment of Eliezer Katz, M.D., FACS as Chief Medical Officer with responsibility for leading the company’s clinical development programs.
Company Info
Location
19900 macarthur blvd.
irvine, california, united states
Additional Info
Eledon Pharmaceuticals is a clinical stage biotechnology company with immunology expertise that is developing therapies to protect and prevent rejection of transplanted organs, as well as to treat amyotrophic lateral sclerosis (ALS). The Company’s lead compound in development is tegoprubart, an anti-CD40L antibody with high affinity for CD40 Ligand (also called “CD154”), a well-validated biological target with broad therapeutic potential.